Clinical Trials

Phase 1 Not yet recruiting

Carcinoma, Hepatocellular

NCT07365839 2026-01-27

CLeAR

20 enrolled

Carcinoma, Hepatocellular

NCT07110233 2026-01-23

Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma

64 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07314372 2026-01-20

FAD-HCC-001

86 enrolled

Carcinoma, Hepatocellular

NCT07351669 2026-01-20

A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma

250 enrolled

Carcinoma, Hepatocellular

NCT07341321 2026-01-14

CoVaCheck

200 enrolled

Carcinoma, Hepatocellular

NCT07337031 2026-01-13

A Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver Cancer

193 enrolled

Carcinoma, Hepatocellular

NCT07312292 2025-12-31

RADIANT

15 enrolled

Phase 2/3 Not yet recruiting

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

NCT07309419 2025-12-30

Cocktail-001

222 enrolled

Carcinoma, Hepatocellular

NCT07268131 2025-12-22

TITAN-HCC

30 enrolled

Carcinoma, Hepatocellular

NCT07281664 2025-12-15

Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma

30 enrolled

Carcinoma, Hepatocellular

NCT07179900 2025-12-11

Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma

60 enrolled

Carcinoma, Hepatocellular

NCT07272083 2025-12-09

CEUS_LR_TRA

200 enrolled

Carcinoma, Hepatocellular

NCT07253220 2025-11-28

TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma

120 enrolled

Hepatitis B, Carcinoma, Hepatocellular

NCT04172779 2025-11-20

ECHO-B

60 enrolled

Carcinoma, Hepatocellular, Liver Cirrhosis

NCT07237204 2025-11-19

15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial

600 enrolled

Phase 1 Not yet recruiting

Carcinoma, Hepatocellular

NCT07075120 2025-10-28

Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer

15 enrolled

Carcinoma, Hepatocellular

NCT07192848 2025-09-25

Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy

47 enrolled

Carcinoma, Hepatocellular

NCT06852820 2025-09-23

68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)

10 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07111130 2025-09-23

RE-BALANCE

90 enrolled

Carcinoma, Hepatocellular, Liver Diseases

NCT07185360 2025-09-22

LIVER-TRACK

845 enrolled

Phase 1/2 Not yet recruiting

Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Hepatic Insufficiency

NCT07187284 2025-09-22

EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial

62 enrolled

Carcinoma, Hepatocellular

NCT07183566 2025-09-19

CT Volume Measurement of Hepatocellular Carcinoma

66 enrolled

Carcinoma, Hepatocellular

NCT07180459 2025-09-18

The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational Study

118 enrolled

Phase 4 Not yet recruiting

Carcinoma, Carcinoma, Hepatocellular

NCT07160361 2025-09-16

Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB

56 enrolled

Carcinoma, Hepatocellular

NCT07159048 2025-09-08

The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors

120 enrolled

Carcinoma, Hepatocellular

NCT07157306 2025-09-05

Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma

35 enrolled

Carcinoma, Hepatocellular

NCT07151326 2025-09-03

CAPIO

60 enrolled

Carcinoma, Hepatocellular

NCT06794073 2025-08-29

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

17 enrolled

Adenocarcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms, Glandular and Epithelial

NCT07142876 2025-08-27

Evaluation Of Liver Resection Using Harmonic Scalpel Versus Cavitron Ultrasonic Surgical Aspirator (CUSA).

50 enrolled

Abdominal Injuries, Carcinoma, Hepatocellular

NCT07131501 2025-08-20

A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma

48 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Carcinoma, Hepatocellular

NCT07130474 2025-08-19

Role of Long Noncoding RNA LINC01134 in Metastasis of Hepatitis C Virus-related Hepatocellular Carcinoma

50 enrolled

Carcinoma, Hepatocellular

NCT07122089 2025-08-14

IOSPHERE

80 enrolled

Carcinoma, Hepatocellular

NCT07120750 2025-08-13

PRTRAS 001

332 enrolled

Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT07117279 2025-08-12

A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular Carcinoma

120 enrolled

Carcinoma, Hepatocellular

NCT07118735 2025-08-12

NCKUH

94 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07115550 2025-08-11

A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular Carcinoma

24 enrolled